Mark Howard Snyder

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ James R. Oehler, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark Howard Snyder

Form 4 holding SVP, CHIEF LEGAL OFFICER

HALOZYME THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
10,068
Estimated value
$1,214,656
Report date
12 Jun 2026
Price
$57.75
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, CHIEF LEGAL OFFICER

HALOZYME THERAPEUTICS, INC.

Security class
Option to Purchase Common Stock
Shares / value
18,730
Estimated value
$313,504
Report date
09 Feb 2026
Price
$13.87
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mark Howard Snyder

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .